Xcenda Expertise Showcased at AMCP Annual Meeting in Boston

April 14, 2018

Join Xcenda at AMCP’s Annual Meeting at the Boston Convention and Exhibition Center, April 23–26. Meet with our commercialization experts at the largest gathering of managed care professionals who work, lead, and innovate in the ever-changing world of pharmaceutical management. Visit us at booth 321.

Xcenda Continues Excellence in Innovative Research

Join us at the AMCP Annual Expo in Boston from April 24 through April 26.

We are proud to "sweep the podium" and present the following award-winning research at AMCP.  Meet our managed markets and global HEOR experts at booth #321.

  Poster   Xcenda Co-authors

 Gold award icon

Payers’ experiences regarding proactive dissemination of health care economic information (HCEI) prior to and after passage of the 21st Century Cures Act  Ena Begovic, Amy Duhig, Jay Jackson, Stewart Kauffman, Janet Hughes, Matt Sarnes, Soumi Saha
Silver award icon
Payers’ perceptions of the importance and usefulness of preapproval information exchange (PIE) of healthcare economic information prior to product approval Ena Begovic, Amy Duhig, Jay Jackson, Stewart Kauffman, Janet Hughes, Matt Sarnes, Soumi Saha
Bronze award icon Payer Evaluation of Organizational Management Approaches to Limit Opioid Abuse and Overdose Deaths in the United States Andrew Gaiser, Maher Abdel-Sattar, Nisreen Shamseddine, Scott Shields
  Payer Perspective on the Academy of Managed Care Pharmacy (AMCP) Format Version 4.0 (v4.0) Pre-approval Dossier in a Managed Care Network Lorie Mody, Kim Boswell, Steve Ren, Stewart Kaufman, Janet Hughes, and Evelyn Sarnes
  The Economic Impact of Emflaza for the Treatment of Duchenne Muscular Dystrophy Rashad Carlton, Tim Regan

 

Heading to Boston? Meet up with Xcenda.

Maximizing patient access for your product.

Contact us to set up a meeting at AMCP Boston. Let's talk about meeting your specific needs.

Contact us

AMCP 2018 Boston Speaker Highlights

Wednesday, April 25, 2018 | 8:30 AM - 9:45 AM | Room: 258 ABC

Best Practices to Implementing Proactive Communications Between Manufacturers and Payers

Panelist: Jay Jackson, PharmD, MPH, Senior Vice President, Consulting Services

Moderator: Soumi Saha, PharmD, JD

The recent enactment of the 21st Century Cures Act, and specifically Section 3037 (Cures 3037), modernized provisions of the Food and Drug Administration Modernization Act of 1997, Section 114 (FDAMA 114), which governs proactive dissemination of health care economic information (HCEI) by manufacturers to payers post-approval. This session will briefly review the evolution of payer and manufacturer communications, and the impact on managed care pharmacy, manufacturers and evidence generators. The panelists will also discuss best practices for operationalizing proactive communications and additional areas for improvement in the future. 

Tuesday, April 24, 2018 | 10:00 AM - 11:00 AM | Room:157 AB 

Importance of Patient Reported Outcomes (PROs)

Faculty: Somali Burgess, PhD

What are patient reported outcomes (PROs), and how are they important to managed care pharmacy? This is the perfect session to build your foundational knowledge on how PROs support better care for patients. PROs use patient experiences with medications and treatments to provide data and feedback, which allows clinicians and patients to choose better interventions to help drive better outcomes and value. While the health care system strives to better use PROs, this session will also discuss challenges and barriers with the implementation of PROs in managed care pharmacy, as well as opportunities to help overcome those barriers and improve patient care.

Wednesday, April 25, 2018 | 6:00 PM - 8:00 PM

Town Hall: Redefining Value Propositions and Managed Care Considerations in Multiple Myeloma

Panelist: Marlo Blazer, PharmD, BCOP

Dr. Blazer will participate as a panelist in this town hall-style open forum to share and discuss the challenges when faced with optimizing outcomes for patients with multiple myeloma (MM) across several lines of therapy. Join this panel in dialogue on risk-stratified approaches, including how to integrate the latest clinical evidence, guidelines, and response monitoring into re-treatment decisions while containing lifetime treatment costs. Interpret the latest real-world data on MM treatment usage, analyze the long-term impact on patients and systems, and consider the value-based implications of sequencing combination regimens through the lens of managed care professionals.

Image of blood with cancer cells in a pipette

Academy of Managed Care Pharmacy’s 2018 New Practitioner Award

Jasmine Knight, PharmD, MS 

We congratulate our own Jasmine Knight for receiving AMCP's 2018 New Practitioner Award. Established in 2015, this prestigious award recognizes an individual making significant contributions to managed care pharmacy within five years of graduation from first professional degree in pharmacy, medicine or nursing. Dr. Knight will be recognized at the Annual Awards Dinner on the evening of Wednesday, April 25, during the AMCP Managed Care & Specialty Pharmacy Annual Meeting in Boston.

Manufacturers: We want to hear from you...

Take our manufacturer survey regarding policy impacts on proactive communication of healthcare economic information (HCEI).

Take survey